BG105126A - Tetrahydronaphthyridinyl-carboxamides have anti-convulsant activity - Google Patents

Tetrahydronaphthyridinyl-carboxamides have anti-convulsant activity

Info

Publication number
BG105126A
BG105126A BG105126A BG10512601A BG105126A BG 105126 A BG105126 A BG 105126A BG 105126 A BG105126 A BG 105126A BG 10512601 A BG10512601 A BG 10512601A BG 105126 A BG105126 A BG 105126A
Authority
BG
Bulgaria
Prior art keywords
alkyl
hydrogen
groups
cycloalkyl
phenyl
Prior art date
Application number
BG105126A
Other languages
Bulgarian (bg)
English (en)
Inventor
John HARLING
Frank Harrington
Mervyn Thompson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BG105126A publication Critical patent/BG105126A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Anesthesiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG105126A 1998-06-12 2001-01-08 Tetrahydronaphthyridinyl-carboxamides have anti-convulsant activity BG105126A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9812683.2A GB9812683D0 (en) 1998-06-12 1998-06-12 Novel compounds
PCT/GB1999/001826 WO1999065903A1 (fr) 1998-06-12 1999-06-09 Tetrahydronaphtyridinyl-carboxamides presentant une activite anti-convulsivante

Publications (1)

Publication Number Publication Date
BG105126A true BG105126A (en) 2001-11-30

Family

ID=10833636

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105126A BG105126A (en) 1998-06-12 2001-01-08 Tetrahydronaphthyridinyl-carboxamides have anti-convulsant activity

Country Status (31)

Country Link
US (2) US6410555B1 (fr)
EP (1) EP1084122B1 (fr)
JP (1) JP2002518390A (fr)
KR (1) KR20010052792A (fr)
CN (1) CN1311789A (fr)
AP (1) AP2000002009A0 (fr)
AR (1) AR018656A1 (fr)
AT (1) ATE252579T1 (fr)
AU (1) AU750470B2 (fr)
BG (1) BG105126A (fr)
BR (1) BR9911110A (fr)
CA (1) CA2334900A1 (fr)
CO (1) CO5040081A1 (fr)
CZ (1) CZ293010B6 (fr)
DE (1) DE69912278T2 (fr)
EA (1) EA200100033A1 (fr)
ES (1) ES2209524T3 (fr)
GB (1) GB9812683D0 (fr)
HU (1) HUP0102773A3 (fr)
ID (1) ID27593A (fr)
IL (1) IL140171A0 (fr)
MA (1) MA26646A1 (fr)
NO (1) NO20006269L (fr)
NZ (1) NZ508799A (fr)
PE (1) PE20000727A1 (fr)
PL (1) PL344791A1 (fr)
SK (1) SK18962000A3 (fr)
TR (1) TR200003694T2 (fr)
TW (1) TW495510B (fr)
WO (1) WO1999065903A1 (fr)
ZA (1) ZA200007397B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds
EP1243263B1 (fr) * 2001-03-21 2002-11-27 Schwarz Pharma Ag Nouvelle utilisation d'une classe de composés peptidiques pour le traitement de l'allodynie ou d'autres types de douleurs chroniques ou fantômes
CA2624625A1 (fr) * 2005-11-04 2007-05-10 Pfizer Limited Derive de tetrahydronaphtyridine
AR092253A1 (es) * 2012-08-27 2015-04-08 Array Biopharma Inc Inhibidores de serina/treonina cinasa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
BR9709906A (pt) * 1996-06-17 1999-08-10 Smithkline Beecham Plc Derivados de benzamida substituídos e o uso dos mesmos como anticonvulsivantes
GB9711257D0 (en) * 1997-05-30 1997-07-30 Smithkline Beecham Plc Novel compounds
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
EP1084122A1 (fr) 2001-03-21
PL344791A1 (en) 2001-11-19
HUP0102773A3 (en) 2002-09-30
EA200100033A1 (ru) 2001-06-25
IL140171A0 (en) 2002-02-10
SK18962000A3 (sk) 2001-08-06
ES2209524T3 (es) 2004-06-16
MA26646A1 (fr) 2004-12-20
CO5040081A1 (es) 2001-05-29
KR20010052792A (ko) 2001-06-25
GB9812683D0 (en) 1998-08-12
AP2000002009A0 (en) 2000-12-31
US6410555B1 (en) 2002-06-25
CZ20004611A3 (en) 2001-06-13
US20020143029A1 (en) 2002-10-03
JP2002518390A (ja) 2002-06-25
TR200003694T2 (tr) 2001-06-21
AU750470B2 (en) 2002-07-18
DE69912278D1 (en) 2003-11-27
CZ293010B6 (cs) 2004-01-14
NO20006269D0 (no) 2000-12-11
CN1311789A (zh) 2001-09-05
TW495510B (en) 2002-07-21
BR9911110A (pt) 2001-10-30
AR018656A1 (es) 2001-11-28
DE69912278T2 (de) 2004-08-12
CA2334900A1 (fr) 1999-12-23
HUP0102773A2 (hu) 2002-01-28
NO20006269L (no) 2001-02-07
ZA200007397B (en) 2002-02-27
US6762192B2 (en) 2004-07-13
ATE252579T1 (de) 2003-11-15
EP1084122B1 (fr) 2003-10-22
NZ508799A (en) 2003-08-29
WO1999065903A1 (fr) 1999-12-23
AU4280099A (en) 2000-01-05
ID27593A (id) 2001-04-12
PE20000727A1 (es) 2000-09-28

Similar Documents

Publication Publication Date Title
IL166784A0 (en) New purine derivatives
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
NO994509D0 (no) Pyrrolo[2,3]pyrimidiner og deres anvendelse som tyrosinaseinhibitorer
MY139357A (en) Novel benzoimidazole derivatives useful as antiproliferative agents
EA200400466A1 (ru) Производные пиперазина с антагонистической активностью к рецептору ccr1
IL166783A0 (en) New purine derivatives
AR029343A1 (es) USO DE UN ANTAGONISTA DE NMDA DE BAJA AFINIDAD PARA EL TRATAMIENTO DE LA DEPRESIoN
FI945581A0 (fi) Substituoidut (aryylialkoksibentsyyli) aminopropaaniamidijohdannaiset, niiden valmistus ja käyttö antiepileptisinä, neuroprotektiivisina ja antidepressiivisinä aineina
IL160874A0 (en) 4-imidazolin-2-one derivatives
BG105126A (en) Tetrahydronaphthyridinyl-carboxamides have anti-convulsant activity
PT1628968E (pt) Compostos de 4-imidazolin-2-ona
AP9901635A0 (en) Anti-convulsant isoquinolyl-benzamide derivatives.
CA2289638A1 (fr) Melanges fongicides
ES8306752A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzamina.
BR9809685B1 (pt) mistura fungicida, processo para controlar fungos nocivos, uso de um composto, e, composição.
AR029375A1 (es) DERIVADOS DE CARBOXAMIDA, UN PROCEDIMIENTO PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACEUTICA QUE LOS COMPRENDE Y EL USO DE DICHO DERIVADO PARA LA FABRICACION DE UN MEDICAMENTO
MY106786A (en) Novel antiviral tetrahydroimidazo [1,4] benzodiazepin -2- (thi)ones
ES458548A1 (es) Procedimiento para la preparacion de derivados de benzamida.
ECSP993010A (es) Compuestos de formula (1) y sus sales y solvatos farmaceuticamente aceptables
TH18470B (th) อนุพันธ์เมลาโทนินสำหรับใช้ในการรักษาความผิดปกติของการหลับ